SELENA Flare Tool

Purpose: To evaluate the severity of a flare in lupus disease activity using the SELENA flare tool.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with systemic lupus erythematosus (SLE)?

Yes

Body weight

Current SLEDAI score

Previous SLEDAI score

Current daily prednisone dose

mg per day

Previous daily prednisone dose

mg per day

Has an NSAID or plaquenil been added or increased to control symptoms?

Yes

Has the patient been started on cytoxan, azathioprine or methotrexate to control symptoms?

Yes

Current physician's assessment in centimeters along an 8 cm VAS scale

Previous physician's assessment in centimeters along an 8 cm VAS scale

Platelet count

Current hemoglobin

g/dL

Previous hemoglobin

g/dL

Select the appropriate answer for each finding

Skin rash

Nasopharyngeal ulcers

Pleuritis

Pericarditis

Arthritis

Fever ascribed to lupus

Systemic vasculitis

Nephritis

Myositis

Immune thrombocytopenia

Immune hemolytic anemia

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Change in SLEDAI score

Current prednisone dose

Number of mild to moderate symptoms

Number of severe symptoms

Number of criteria indicating no change or better

Number of criteria indicating mild to moderate flare

Number of criteria indicating severe flare

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
Imaging Studies
Laboratory Tests
Other Testing
- Clinical Features of Acute Lupus Pneumonitis
Criteria For Diagnosis
Severity, Prognosis, Stage
Complications
- Systemic Lupus Erythematosus (SLE) | Moyamoya Syndrome
Differential Diagnosis And Mimics, Red Flags

Therapy

Pharmacogenetics
- Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL)
- Shrinking Lungs Syndrome (SLS) | Systemic Lupus Erythematosus
Drug Interactions
- Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL)
Prevention
Interventional Radiology

Monitoring

Drug Levels
- Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL)
Disease Progression
Complication Detection
Comorbid Conditions

Patient Concerns

Quality Of Life
Psychological Response

Specialty

Immunology/Rheumatology

Objective

risk factors
clinical diagnosis
including family history for genetics
laboratory tests
pharmacogenetics
drug interactions
drug levels
complication detection
prevention

ICD-10

M32.0 - Drug-induced systemic lupus erythematosus
M32.1 - Systemic lupus erythematosus with organ or system involvement
M32.8 - Other forms of systemic lupus erythematosus
M32.9 - Systemic lupus erythematosus, unspecified

Info

Purpose: To evaluate the severity of a flare in lupus disease activity using the SELENA flare tool.

Specialty: Immunology/Rheumatology

Objective: risk factors, clinical diagnosis, including family history for genetics, laboratory tests, pharmacogenetics, drug interactions, drug levels, complication detection, prevention

ICD-10: M32.0, M32.1, M32.8, M32.9,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path